Text

Linking gut microbiota diversity to survival outcomes in children’s stem cell transplants

Results from a recent study suggest a correlation between the diversity and composition of the gut microbiota prior to transplantation and both the patient's survival and the probability of developing…

Mixture of milk sugars and live bacteria may restore damaged gut microbiotas

The findings of a recent study suggest that a mixture of B. infantis and HMOs can modulate the gut microbiota in adults.

Dietary intervention may change the microbiota, alleviate fatty liver disease

The findings of a recent study suggest that resistant-starch supplements can alter the gut microbiota in ways that alleviate NAFLD.

Boehringer Ingelheim acquires T3 Pharma, boosting immuno-oncology efforts

In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.

In silico trials: the avant-garde of clinical trials in support of Biofarma Group’s product Epatrex

Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.

Socio-economic adversities are associated with gut microbiota alterations

Microbial differences may help to identify targets that could be modulated to mitigate health inequities.

The impact of gut bacteria on micronutrient status in the host

The interplay between micronutrients and the microbiome is a significant factor in determining the risk of vitamin and mineral deficiencies, which has implications for global public health.

Cutting-edge human milk-derived therapy: a revolutionary approach in treating blood cancers

The therapy, combining human milk oligosaccharides (HMOs) and a specific gut bacteria strain, represents not only a scientific breakthrough but also holds substantial economic implications.

How sugar changes the metabolism of cavity-causing bacteria

The findings suggest that lysine lactylation contributes to metabolic regulation in bacteria and that GNAT13 may limit sucrose-driven biofilm formation.

How Akkermansia and Lactobacillus plantarum could revolutionize treatment for Lupus through immune regulation

This study demonstrated fundamental mechanisms through which A. muciniphila and L. plantarum modify the gut microbiota and control immune responses in the SLE mouse model.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top